Improved efficacy of therapeutic vaccination with viable human umbilical vein endothelial cells against murine melanoma by introduction of OK432 as adjuvant-Reference-Cited by-同舟云学术

Improved efficacy of therapeutic vaccination with viable human umbilical vein endothelial cells against murine melanoma by introduction of OK432 as adjuvant

Published:2013-03-01 Issue:3 Volume:34 Page:1399-1408
ISSN:1010-4283
Container-title:Tumor Biology
language:en
Short-container-title:Tumor Biol.

Author:

Xu Maolei,Xing Yun,Zhou Ling,Yang Xue,Yao Wenjun,Xiao Wen,Ge Chiyu,Ma Yanjun,Yang Jie,Wu Jie,Cao Rongyue,Li Taiming,Liu Jingjing

Publisher

Springer Science and Business Media LLC

Subject

General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s13277-012-0616-8.pdf

Reference31 articles.

1. Chen IJ, Yen CF, Lin KJ, Lee CL, Soong YK, Lai CH, Lin CT. Vaccination with OK-432 followed by TC-1 tumor lysate leads to significant antitumor effects. Reprod Sci. 2011;18(7):687–94. doi: 10.1177/1933719110396230 .

2. Huang L, Ohno T. Protective antitumor immunity induced by fixed tumor cells in combination with adjuvant in a murine hepatoma model. Cancer Lett. 2003;202(2):153–9.

3. Novakovic S, Stegel V, Kopitar A, Ihan A, Novakovic BJ. Preventive and therapeutic antitumor effect of tumor vaccine composed of CpG ODN class C and irradiated tumor cells is triggered through the APCs and activation of CTLs. Vaccine. 2007;25(49):8241–56. doi: 10.1016/j.vaccine.2007.09.067 .

4. Suckow MA, Rosen ED, Wolter WR, Sailes V, Jeffrey R, Tenniswood M. Prevention of human PC-346C prostate cancer growth in mice by a xenogeneic tissue vaccine. Cancer Immunol Immunother. 2007;56(8):1275–83. doi: 10.1007/s00262-006-0278-8 .

5. Yin W, He Q, Hu Z, Chen Z, Qifeng M, Zhichun S, Zhihui Q, Xiaoxia N, Li J, Gao J. A novel therapeutic vaccine of GM-CSF/TNFalpha surface-modified RM-1 cells against the orthotopic prostatic cancer. Vaccine. 2010;28(31):4937–44.

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Vaccines targeting angiogenesis in melanoma;European Journal of Pharmacology;2021-12

2. Low-dose docetaxel enhances the anti-tumour efficacy of a human umbilical vein endothelial cell vaccine;European Journal of Pharmaceutical Sciences;2020-01

3. Combination of Human Umbilical Vein Endothelial Cell Vaccine and Docetaxel Generates Synergistic Anti-Breast Cancer Effects;Cancer Biotherapy and Radiopharmaceuticals;2019-09-01

4. Improved Antitumor Efficacy of Combined Vaccine Based on the Induced HUVECs and DC-CT26 Against Colorectal Carcinoma;Cells;2019-05-22

5. Human umbilical vein endothelial cell vaccine suppresses the angiogenesis of esophageal squamous cell carcinoma in a humanized mouse model;Oncology Reports;2018-08-17